Seraph® Clinical Trial
ExThera Medical is sponsoring a prospective, multi-center, non-randomized European trial for the Seraph® Microbind® Affinity Blood Filter (Seraph). The study will enroll 15 patients at up to five centers in Germany.
The trial is designed to determine the safety and performance of the Seraph for reducing bacteremia in patients on hemodialysis, including MRSA, S. aureus, K. pneumoniae (CRE), K. pneumoniae, E. coli (CRE), E. coli, S. pneumoniae, E. faecalis, E. faecalis (VRE), E. faecium, A. baumannii, S. epidermidis, Methicillin resistant S. epidermidis, S. pyogenes, and Serratia marcescens.
Additional details about the study can be obtained by visiting https://clinicaltrials.gov/show/NCT02914132. CinicalTrials.gov Identifier: NCT02914132